- It's not too early to gauge the level of investor interest in Stemina Biomarker Discovery, Inc., a new company formed by Beth Donley and University of Wisconsin-Madison
stem cell scientist Gabriela Cezar.
Donley already is rubbing elbows with interested investors, particularly angels, but she knows that one of the key criteria for e......Full article >>>
stem cells emit when exposed to disease factors or drugs. These biomarkers can be predictive of disease and used to screen drugs. For example, exposing stem cells to drugs that are known to cause birth defects reveals certain biomarkers that can be used to identify other dangerous drugs.
Cezar said other stem cell initiatives are focusing on standardized tests, whereas biomarkers are an......Full article >>>
nsists of research labs and pharmaceutical companies.
Bringing down the cost of drug development is another potential benefit of Cezar's research. By using human cells as part of early screening, researchers might be able to more quickly identify drugs that are going to fail, saving money for pharmaceutical companies and, theoretically, the consumer.
"It's a technology that reall......Full article >>>
Source:wistechnology.com By Joe Vanden Plas 12/12/06Related biology technology :1
. Kyron appoints former AMA chairman to board2
. Genzyme sues former Bone Care employees3
. New book from former CDC CEO walks readers through innovation4
. Are top performers born or made?5
. Searle spirit lives on in Chicago as alumni celebrate at former home6
. PDS hires new VP, buys former health club building7
. Online aid group taps former Wisconsin governor McCallum8
. Donley resigns as WiCell director9
. WiCell, California firm agree to distribute stem cell lines derived with new technique10
. WiCell to host new national stem cell bank11
. Sharon Ethanol appoints operations director